IUKL Library
Normal view MARC view ISBD view

Quantitative Models in Life Science Business : From Value Creation to Business Processes.

By: Canci, Jung Kyu.
Contributor(s): Mekler, Philipp | Mu, Gang.
Material type: materialTypeLabelBookSeries: SpringerBriefs in Economics Series: Publisher: Cham : Springer International Publishing AG, 2022Copyright date: �2023Edition: 1st ed.Description: 1 online resource (131 pages).Content type: text Media type: computer Carrier type: online resourceISBN: 9783031118142.Genre/Form: Electronic books.Online resources: Click to View
Contents:
Intro -- Preface -- Acknowledgments -- Contents -- *-1pc Value Creation and Managing Intellectual Property in the Life Science Industry -- Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- 1 Value Principles in the Pharmaceutical Industry -- 2 Value Creation in the Pharmaceutical Industry -- 3 `Keeping Focus': The Traditional Value Token -- 4 `Extending Horizons': Innovation-Integration Across the Value Chain -- 5 Value Protection: Intellectual Property in the Life Sciences -- 5.1 Patent Evaluation -- 6 Modelling the Patent Value as a Stochastic Process -- 6.1 The Patent Life Model -- 6.2 Viewing a Generic Case -- 6.3 Interferon Beta 1a: A Real-World Case -- 7 The Future of Value and Valuation in Pharma -- References -- Limited Commercial Licensing Strategies: A Piecewise Deterministic Differential Game -- 1 Limited Commercial Licenses in the Pharmaceutical Industry -- 1.1 Probability of Issuing a CL -- 2 A Differential Game of Limited Commercial Licensing -- 2.1 Preliminaries -- 2.2 Profits and Sales in Each Regime -- 2.3 Switching Between Stages -- 2.4 The Problem -- 3 Solving the Model -- 4 Perspective -- References -- Partnership Models for R&amp -- D in the Pharmaceutical Industry -- 1 Introduction -- 2 The Problem of R&amp -- D Efficiency of Pharmaceutical Companies -- 2.1 Eroom's Law -- 2.2 Analysis of R&amp -- D Costs in the Pharmaceutical Sector -- 2.3 Analysis of Pipeline Drugs -- 3 New R&amp -- D Open Innovation Models for Pharmaceutical Companies -- 3.1 Mergers and Acquisitions -- 3.2 In-licensing Agreements -- 3.3 Outsourcing R&amp -- D Processes from CROs -- 3.4 R&amp -- D Collaborations -- 3.5 Public-Private Partnerships -- 3.6 Crowdsourcing -- 3.7 Innovation Centers -- 3.8 Open Source -- References -- *-1pc Modelling Specific Business Processes in the Life Science Industry.
Pharma Tender Processes: Modeling Auction Outcomes -- 1 Introduction -- 2 Pharmaceutical Tendering -- 2.1 Pharmaceutical Tendering Mechanism in Different Countries -- 2.2 Effect of Pharmaceutical Tendering -- 3 Tendering as Auction: Scope and Concept -- 3.1 Tender Versus Auction -- 3.2 Independent Private Value Auction -- 3.3 First Price Sealed Auction -- 3.4 Number of Bidders -- 4 Empirical Methods for Price Auction Estimation -- 4.1 Bidding Price Determinants Estimation with Reduced Form Approach -- 4.2 Structural Estimation of Auction Models -- 4.3 Quantile-Based Non-parametric Estimation of Private Value -- 5 Non-parametric Estimation on Observational Data -- 5.1 Dataset -- 5.2 Visualization and Descriptive Analysis -- 5.3 Assumptions Validation -- 5.4 Modeling and Estimation -- 5.5 Adjustments and Lessons Learned -- References -- Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- 1 Introduction -- 2 Challenges of Multi-Echelon Inventory Management from an Optimization Perspective -- 3 Literature Review of Inventory Management -- 4 Reinforcement Learning for Inventory Management -- 4.1 Markov (Decision) Processes -- 5 Introduction to Reinforcement Learning -- 5.1 Value-Based Methods -- 5.2 Policy-Based Methods -- 5.3 Actor-Critic Methods -- 6 Evaluation -- 7 Discussion of Results -- 8 Outlook -- 9 Conclusions -- 10 Acronyms -- References -- *-1pc Specialized Quantitative Tools in the Life Science Industry -- An Invitation to Stochastic Differential Equations in Healthcare -- 1 Introduction -- 1.1 Brownian Motions -- 1.2 Ito's Integral and Solutions of Geometric Brownian Motions (GBM) -- 1.3 Existence of Solutions of Stochastic Differential Equations -- 2 Numerical Methods for SDEs -- 2.1 Euler-Maruyama Method -- 2.2 -Maruyama Methods -- 2.3 Stochastic Runge-Kutta Methods -- 3 A Numerical Evidence on PK/PD Models.
References -- Life Events that Cascade: An Excursion into DALY Computations -- 1 Introduction -- 2 The Hawkes-Cox Framework -- 2.1 The Choice of Kernel and the R�ole of (Se(B -- 3 Dynkin's Formula -- 4 Theoretical Moments -- 4.1 The Moments of Counts in an Interval -- 4.2 The Covariance -- 5 Learning and Optimization -- 6 Synthetic Experiments -- 6.1 Calibration -- 7 Disability Adjusted Life Years -- 8 Concluding Remarks -- References.
Tags from this library: No tags from this library for this title. Log in to add tags.
Item type Current location Collection Call number Copy number Status Date due Item holds
E-book E-book IUKL Library
Subscripti 1 Available
Total holds: 0

Intro -- Preface -- Acknowledgments -- Contents -- *-1pc Value Creation and Managing Intellectual Property in the Life Science Industry -- Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- 1 Value Principles in the Pharmaceutical Industry -- 2 Value Creation in the Pharmaceutical Industry -- 3 `Keeping Focus': The Traditional Value Token -- 4 `Extending Horizons': Innovation-Integration Across the Value Chain -- 5 Value Protection: Intellectual Property in the Life Sciences -- 5.1 Patent Evaluation -- 6 Modelling the Patent Value as a Stochastic Process -- 6.1 The Patent Life Model -- 6.2 Viewing a Generic Case -- 6.3 Interferon Beta 1a: A Real-World Case -- 7 The Future of Value and Valuation in Pharma -- References -- Limited Commercial Licensing Strategies: A Piecewise Deterministic Differential Game -- 1 Limited Commercial Licenses in the Pharmaceutical Industry -- 1.1 Probability of Issuing a CL -- 2 A Differential Game of Limited Commercial Licensing -- 2.1 Preliminaries -- 2.2 Profits and Sales in Each Regime -- 2.3 Switching Between Stages -- 2.4 The Problem -- 3 Solving the Model -- 4 Perspective -- References -- Partnership Models for R& -- D in the Pharmaceutical Industry -- 1 Introduction -- 2 The Problem of R& -- D Efficiency of Pharmaceutical Companies -- 2.1 Eroom's Law -- 2.2 Analysis of R& -- D Costs in the Pharmaceutical Sector -- 2.3 Analysis of Pipeline Drugs -- 3 New R& -- D Open Innovation Models for Pharmaceutical Companies -- 3.1 Mergers and Acquisitions -- 3.2 In-licensing Agreements -- 3.3 Outsourcing R& -- D Processes from CROs -- 3.4 R& -- D Collaborations -- 3.5 Public-Private Partnerships -- 3.6 Crowdsourcing -- 3.7 Innovation Centers -- 3.8 Open Source -- References -- *-1pc Modelling Specific Business Processes in the Life Science Industry.

Pharma Tender Processes: Modeling Auction Outcomes -- 1 Introduction -- 2 Pharmaceutical Tendering -- 2.1 Pharmaceutical Tendering Mechanism in Different Countries -- 2.2 Effect of Pharmaceutical Tendering -- 3 Tendering as Auction: Scope and Concept -- 3.1 Tender Versus Auction -- 3.2 Independent Private Value Auction -- 3.3 First Price Sealed Auction -- 3.4 Number of Bidders -- 4 Empirical Methods for Price Auction Estimation -- 4.1 Bidding Price Determinants Estimation with Reduced Form Approach -- 4.2 Structural Estimation of Auction Models -- 4.3 Quantile-Based Non-parametric Estimation of Private Value -- 5 Non-parametric Estimation on Observational Data -- 5.1 Dataset -- 5.2 Visualization and Descriptive Analysis -- 5.3 Assumptions Validation -- 5.4 Modeling and Estimation -- 5.5 Adjustments and Lessons Learned -- References -- Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- 1 Introduction -- 2 Challenges of Multi-Echelon Inventory Management from an Optimization Perspective -- 3 Literature Review of Inventory Management -- 4 Reinforcement Learning for Inventory Management -- 4.1 Markov (Decision) Processes -- 5 Introduction to Reinforcement Learning -- 5.1 Value-Based Methods -- 5.2 Policy-Based Methods -- 5.3 Actor-Critic Methods -- 6 Evaluation -- 7 Discussion of Results -- 8 Outlook -- 9 Conclusions -- 10 Acronyms -- References -- *-1pc Specialized Quantitative Tools in the Life Science Industry -- An Invitation to Stochastic Differential Equations in Healthcare -- 1 Introduction -- 1.1 Brownian Motions -- 1.2 Ito's Integral and Solutions of Geometric Brownian Motions (GBM) -- 1.3 Existence of Solutions of Stochastic Differential Equations -- 2 Numerical Methods for SDEs -- 2.1 Euler-Maruyama Method -- 2.2 -Maruyama Methods -- 2.3 Stochastic Runge-Kutta Methods -- 3 A Numerical Evidence on PK/PD Models.

References -- Life Events that Cascade: An Excursion into DALY Computations -- 1 Introduction -- 2 The Hawkes-Cox Framework -- 2.1 The Choice of Kernel and the R�ole of (Se(B -- 3 Dynkin's Formula -- 4 Theoretical Moments -- 4.1 The Moments of Counts in an Interval -- 4.2 The Covariance -- 5 Learning and Optimization -- 6 Synthetic Experiments -- 6.1 Calibration -- 7 Disability Adjusted Life Years -- 8 Concluding Remarks -- References.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2023. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments for this item.

Log in to your account to post a comment.
The Library's homepage is at http://library.iukl.edu.my/.